RA
Raihan Abdul Sattar Patel
About Raihan Abdul Sattar Patel
Data last updated:
Raihan Abdul Sattar Patel has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Health Line Pharmaceuticals Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Health Line Pharmaceuticals Private Limited at ₹23.25 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Health Line Pharmaceuticals Private Limited U33110MH2007PTC169349 | Director | 18 Mar 2010 | 2007 | ₹23.25 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raihan Abdul Sattar Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raihan Abdul Sattar Patel
Raihan Abdul Sattar Patel has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Health Line Pharmaceuticals Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Health Line Pharmaceuticals Private Limited at ₹23.25 Cr (FY 2025).
Raihan Abdul Sattar Patel is associated with 1 company as Director, including Health Line Pharmaceuticals Private Limited (₹23.25 Cr).
Raihan Abdul Sattar Patel has expertise in Healthcare.
Raihan Abdul Sattar Patel has 16 years in corporate governance.
By reported revenue, the largest current company of Raihan Abdul Sattar Patel is Health Line Pharmaceuticals Private Limited, with revenue of ₹23.25 Cr (FY 2025).
Raihan Abdul Sattar Patel currently holds positions at 1 company: Health Line Pharmaceuticals Private Limited (₹23.25 Cr).